8-K
Current Report
GALECTIN THERAPEUTICS INC Filed Acc 0001140361-25-025295
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ef20051584_8k.htm…